[The therapeutic situation and advancement in choroidal neovascularization].
Choroidal neovascularization (CNV) caused by multi-etiological factors is one of the most common reasons of visual loss. In recent studies, photodynamic therapy is the major treatment to sub-foveal CNV, and other anti-neovascular and anti-inflammatory agents were applied in clinical practice. In order to maximize the therapeutic effects and minimize the complications, combination management will be possibly applied by influencing multiple mechanisms.